{"entity":{"id":"nct00889525","kind":"trial","name":"Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor","aka":[],"tldr":"A phase 3 trial of Cabergoline in Pituitary tumours, run by Seth Gordhandas Sunderdas Medical College, completed.","summary":"Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor is a phase 3 interventional study registered as NCT00889525 by Seth Gordhandas Sunderdas Medical College, started 2007-11. Interventions recorded: Cabergoline. Conditions recorded: Cushing's Disease, Corticotroph Adenoma.\n\nLinked to the drug Cabergoline because the registry names it among its interventions and Pituitary tumours among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00889525","url":"https://clinicaltrials.gov/study/NCT00889525"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["pituitary-tumours"],"sections":[],"technologies":[],"targets":[],"drugs":["cabergoline"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00889525","phase":"3","setting":"Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor","sponsor":"Seth Gordhandas Sunderdas Medical College","enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00889525/","neighbours":{"cancer":[{"id":"pituitary-tumours","kind":"cancer","name":"Pituitary tumours (pituitary neuroendocrine tumours) and pituitary carcinoma","route":"/cancers/pituitary-tumours/"}],"drug":[{"id":"cabergoline","kind":"drug","name":"Cabergoline","route":"/drugs/cabergoline/"}]}}